Skip to main content

Vyant Bio, Inc.

VYNTDelisted May 4, 2023
Industry
Services-Medical Laboratories
SEC CIK
0001349929

Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.

13F holders, Q1 2021

Institutional positions in Vyant Bio, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
No complete 13F data for Q4 2020
Shares held
647.7K
No complete 13F data for Q4 2020
Total value
$2.96M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting VYNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 18 institutions
Q1 2021: 18 institutionsQ2 2021: 29 institutionsQ3 2021: 23 institutionsQ4 2021: 27 institutionsQ1 2022: 23 institutionsQ2 2022: 21 institutionsQ3 2022: 26 institutionsQ4 2022: 17 institutionsQ1 2023: 17 institutionsQ2 2023: 1 institutionQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2021: $2.96M
Q1 2021: $2.96MQ2 2021: $8.41MQ3 2021: $5.27MQ4 2021: $3.12MQ1 2022: $2.54MQ2 2022: $1.47MQ3 2022: $949.3KQ4 2022: $222.1KQ1 2023: $136.8KQ2 2023: $1Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VYNT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20231$1
Q1 202317$136.8K
Q4 202217$222.1K
Q3 202226$949.3K
Q2 202221$1.47M
Q1 202223$2.54M
Q4 202127$3.12M
Q3 202123$5.27M
Q2 202129$8.41M
Q1 202118$2.96M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Vyant Bio, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding VYNT in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC180,926$839.0K0.00%––
BlackRock Inc.164,647$764.0K0.00%––
Vanguard Group Inc85,498$396.0K0.00%––
Geode Capital Management, LLC58,305$270.0K0.00%––
GWM Advisors LLC56,017$260.0K0.01%––
Virtu Financial LLC39,211$182.0K0.01%––
Northern Trust Corp19,599$91.0K0.00%––
QCM Cayman, Ltd.10,785$50.0K0.15%––
Citigroup Inc10,000$46.0K0.00%––
Country Club Trust Company, n.a.20,000$45.0K0.00%––
US Bancorp800$4.00K0.00%––
UBS Group AG815$4.00K0.00%––
Advisor Group Holdings, Inc.400$2.00K0.00%––
Morgan Stanley265$1.00K0.00%––
Tower Research Capital LLC (TRC)301$1.00K0.00%––
Wells Fargo & Company74$00.00%––
Captrust Financial Advisors50$00.00%––
Eudaimonia Partners, LLC30$00.00%––